Synthetic cannabinoid poisoning
Synthetic cannabinoids may be sprayed onto plant material and smoked, mixed into a liquid and vaped, or ingested. They are marketed under a variety of names including K2 and Spice. Synthetic cannabinoid products are sometimes sold in convenience stores as aromatherapy agents and may be labeled "not for human consumption." Many variations are now identified as Schedule I controlled substances in the United States, although new varieties continue to appear on the market. Manufacturers frequently alter the chemical composition of the products in an effort to circumvent existing state and federal laws.
Clinical features of synthetic cannabinoid poisoning vary and include neurologic, psychiatric, cardiovascular, and gastrointestinal symptoms as well as seizures, rhabdomyolysis, kidney failure, and death. Outbreaks have been identified by clusters of emergency department visits and poison center calls for illness due to synthetic cannabinoid use. Commonly reported adverse effects include tachycardia, tachypnea, increased blood pressure, vomiting, agitation, aggression / violent behavior, somnolence, and delirium / confusion.
T40.7X5A – Adverse effect of cannabis (derivatives), initial encounter
737335004 – Synthetic cannabinoid intoxication